538 related articles for article (PubMed ID: 9155585)
1. Antineutrophil cytoplasm autoantibodies against bactericidal/permeability-increasing protein in inflammatory bowel disease.
Walmsley RS; Zhao MH; Hamilton MI; Brownlee A; Chapman P; Pounder RE; Wakefield AJ; Lockwood CM
Gut; 1997 Jan; 40(1):105-9. PubMed ID: 9155585
[TBL] [Abstract][Full Text] [Related]
2. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.
Xin G; Zhao MH; Wang HY
Clin Diagn Lab Immunol; 2004 May; 11(3):559-62. PubMed ID: 15138182
[TBL] [Abstract][Full Text] [Related]
3. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease.
Kossa K; Coulthart A; Ives CT; Pusey CD; Hodgson HJ
Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):783-9. PubMed ID: 7496870
[TBL] [Abstract][Full Text] [Related]
4. Anti-neutrophil cytoplasmic antibodies in patients with chronic liver diseases: prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease. Swedish Internal Medicine Liver Club (SILK).
Lindgren S; Nilsson S; Nässberger L; Verbaan H; Wieslander J
J Gastroenterol Hepatol; 2000 Apr; 15(4):437-42. PubMed ID: 10824890
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies against the bactericidal/permeability-increasing protein from inflammatory bowel disease patients can impair the antibiotic activity of bactericidal/permeability-increasing protein.
Schinke S; Fellermann K; Herlyn K; Reichel PH; Fundke R; Stange EF; Gross WL; Schultz H
Inflamm Bowel Dis; 2004 Nov; 10(6):763-70. PubMed ID: 15626895
[TBL] [Abstract][Full Text] [Related]
6. Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens.
Sugi K; Saitoh O; Matsuse R; Tabata K; Uchida K; Kojima K; Nakagawa K; Tanaka S; Teranishi T; Hirata I; Katsu K
Am J Gastroenterol; 1999 May; 94(5):1304-12. PubMed ID: 10235211
[TBL] [Abstract][Full Text] [Related]
7. Anti-neutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Prevalence and diagnostic role.
Hertervig E; Wieslander J; Johansson C; Wiik A; Nilsson A
Scand J Gastroenterol; 1995 Jul; 30(7):693-8. PubMed ID: 7481534
[TBL] [Abstract][Full Text] [Related]
8. Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis.
Halbwachs-Mecarelli L; Nusbaum P; Noël LH; Reumaux D; Erlinger S; Grünfeld JP; Lesavre P
Clin Exp Immunol; 1992 Oct; 90(1):79-84. PubMed ID: 1327593
[TBL] [Abstract][Full Text] [Related]
9. Bactericidal/permeability-increasing protein and cathepsin G are the major antigenic targets of antineutrophil cytoplasmic autoantibodies in systemic sclerosis.
Khanna D; Aggarwal A; Bhakuni DS; Dayal R; Misra R
J Rheumatol; 2003 Jun; 30(6):1248-52. PubMed ID: 12784398
[TBL] [Abstract][Full Text] [Related]
10. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives.
Radice A; Vecchi M; Bianchi MB; Sinico RA
Clin Exp Rheumatol; 2000; 18(6):707-12. PubMed ID: 11138332
[TBL] [Abstract][Full Text] [Related]
11. Antineutrophil cytoplasmic antibodies (ANCAs) in patients with inflammatory bowel disease show no correlation with proteinase 3, lactoferrin, myeloperoxidase, elastase, cathepsin G and lysozyme: a Singapore study.
Ooi CJ; Lim BL; Cheong WK; Ling AE; Ng HS
Ann Acad Med Singap; 2000 Nov; 29(6):704-7. PubMed ID: 11269973
[TBL] [Abstract][Full Text] [Related]
12. [Bactericidal permeability increasing protein (BPI-ANCA marked chronic inflammatory bowel diseases and hepatobiliary diseases].
Schnabel A; Csernok E; Schultz H; Stoffel M; Herzberg C; Carroll SF; Gross WL
Med Klin (Munich); 1997 Jul; 92(7):389-93. PubMed ID: 9324622
[TBL] [Abstract][Full Text] [Related]
13. Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus: prevalence, antigen specificity, and clinical associations.
Manolova I; Dancheva M; Halacheva K
Rheumatol Int; 2001 Jul; 20(5):197-204. PubMed ID: 11518040
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA).
Talor MV; Stone JH; Stebbing J; Barin J; Rose NR; Burek CL
Clin Exp Immunol; 2007 Oct; 150(1):42-8. PubMed ID: 17614969
[TBL] [Abstract][Full Text] [Related]
15. Alpha1-antitrypsin phenotypes and anti-neutrophil cytoplasmic auto-antibodies in inflammatory bowel disease.
Taddei C; Audrain MA; Reumaux D; Sesboüe R; Testa A; Galmiche JP; Duthilleul P; Colombel JF; Esnault VL
Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1293-8. PubMed ID: 10563543
[TBL] [Abstract][Full Text] [Related]
16. Recognition of bactericidal/permeability-increasing protein by perinuclear anti-neutrophil cytoplasmic antibody-positive sera from ulcerative colitis patients: prevalence and clinical significance.
Vecchi M; Sinico A; Bianchi MB; Radice A; Gionchetti P; Campieri M; de Franchis R
Scand J Gastroenterol; 1998 Dec; 33(12):1284-8. PubMed ID: 9930392
[TBL] [Abstract][Full Text] [Related]
17. Analysis of anti-neutrophil cytoplasmic antibodies (ANCA): frequency and specificity in a sample of 191 homozygous (PiZZ) alpha1-antitrypsin-deficient subjects.
Audrain MA; Sesboüé R; Baranger TA; Elliott J; Testa A; Martin JP; Lockwood CM; Esnault VL
Nephrol Dial Transplant; 2001 Jan; 16(1):39-44. PubMed ID: 11208991
[TBL] [Abstract][Full Text] [Related]
18. Antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis after immunisation with bacterial proteins.
Savige J; Nassis L; Cooper T; Paspaliaris B; Martinello P; MacGregor D
Clin Exp Rheumatol; 2002; 20(6):783-9. PubMed ID: 12508769
[TBL] [Abstract][Full Text] [Related]
19. p-ANCA target antigens in ulcerative colitis.
Folwaczny C; Jochum M; Noehl N; Schnettler D; Loeschke K; Fricke H
Z Gastroenterol; 1998 Aug; 36(8):625-33. PubMed ID: 9773480
[TBL] [Abstract][Full Text] [Related]
20. Distinct patterns of immunoglobulin classes and IgG subclasses of autoantibodies in patients with inflammatory bowel disease.
Müller-Ladner U; Gross V; Andus T; Gschwendtner H; Roth M; Caesar I; Schölmerich J; Lang B
Eur J Gastroenterol Hepatol; 1996 Jun; 8(6):579-84. PubMed ID: 8823574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]